Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$214M |
| 2 |
Verizon
VZ
|
+$148M |
| 3 |
Otis Worldwide
OTIS
|
+$142M |
| 4 |
Baidu
BIDU
|
+$124M |
| 5 |
Alibaba
BABA
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$324M |
| 2 |
Amazon
AMZN
|
+$313M |
| 3 |
Bank of America
BAC
|
+$264M |
| 4 |
AGN
Allergan plc
AGN
|
+$259M |
| 5 |
Wells Fargo
WFC
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 12.76% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBC
2476
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $5M | ﹤0.01% |
500,430
+112,390
| +29% | +$1.08M |
|
2477
Consumer Portfolio Services
CPSS
$209M
| $5M | ﹤0.01% |
1,765,238
-44,088
| -2% | -$110K |
|
2478
Celestica
CLS
$37.8B
| $4.98M | ﹤0.01% |
729,018
+6,300
| +0.9% | +$36K |
|
2479
Mitek Systems
MITK
$756M
| $4.97M | ﹤0.01% |
516,918
+33,575
| +7% | +$303K |
|
|
BOCH
2480
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $4.95M | ﹤0.01% |
653,570
+28,143
| +4% | +$206K |
|
|
HMNF
2481
DELISTED
HMN Financial Inc
HMNF
| $4.9M | ﹤0.01% |
333,816
-1,519
| -0.5% | -$23.1K |
|
|
ARA
2482
DELISTED
American Renal Associates Holdings, Inc
ARA
| $4.89M | ﹤0.01% |
750,373
-25,101
| -3% | -$162K |
|
|
EVOP
2483
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $4.85M | ﹤0.01% |
212,379
+16,516
| +8% | +$328K |
|
2484
Stantec
STN
$8.17B
| $4.82M | ﹤0.01% |
156,350
+21,586
| +16% | +$630K |
|
2485
STRATTEC Security
STRT
$376M
| $4.81M | ﹤0.01% |
301,512
-911
| -0.3% | -$13.9K |
|
2486
PG&E
PCG
$39B
| $4.79M | ﹤0.01% |
539,228
-8,497
| -2% | -$92.6K |
|
|
PCSB
2487
DELISTED
PCSB Financial Corporation
PCSB
| $4.78M | ﹤0.01% |
376,554
+32,155
| +9% | +$419K |
|
|
OTIC
2488
DELISTED
Otonomy, Inc.
OTIC
| $4.78M | ﹤0.01% |
1,319,167
-23,188
| -2% | -$60.4K |
|
|
INWK
2489
DELISTED
InnerWorkings, Inc.
INWK
| $4.77M | ﹤0.01% |
3,614,547
-405,554
| -10% | -$540K |
|
|
SBBX
2490
DELISTED
SB One Bancorp Common Stock
SBBX
| $4.77M | ﹤0.01% |
242,190
+19,523
| +9% | +$339K |
|
2491
Eldorado Gold
EGO
$8.33B
| $4.76M | ﹤0.01% |
491,076
+258,452
| +111% | +$2.24M |
|
2492
CytomX Therapeutics
CTMX
$690M
| $4.75M | ﹤0.01% |
570,604
-23,063
| -4% | -$214K |
|
2493
Nature's Sunshine
NATR
$362M
| $4.75M | ﹤0.01% |
526,784
+970
| +0.2% | +$8.43K |
|
|
MFNC
2494
DELISTED
Mackinac Financial Corporation
MFNC
| $4.74M | ﹤0.01% |
457,223
+12,571
| +3% | +$124K |
|
2495
Thomson Reuters
TRI
$46.4B
| $4.74M | ﹤0.01% |
66,113
+2,360
| +4% | +$171K |
|
|
GBL
2496
DELISTED
GAMCO Investors, Inc.
GBL
| $4.73M | ﹤0.01% |
355,541
-8,210
| -2% | -$102K |
|
2497
Altisource Portfolio Solutions
ASPS
$57.6M
| $4.73M | ﹤0.01% |
40,114
-567
| -1% | -$46.6K |
|
2498
Minerva Neurosciences
NERV
$191M
| $4.69M | ﹤0.01% |
162,263
-26,571
| -14% | -$1.56M |
|
2499
Accuray
ARAY
$27.5M
| $4.67M | ﹤0.01% |
2,301,391
-10,886
| -0.5% | -$22.7K |
|
|
MRSN
2500
DELISTED
Mersana Therapeutics
MRSN
| $4.66M | ﹤0.01% |
7,964
-81
| -1% | -$27.7K |
|
Similar funds
Dimensional Fund Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
- Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
- Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
- Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
- Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
- Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.